SUPREME-HN: a retrospective biomarker study assessing the prognostic value of PD-L1 expression in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
- Publication date
- 1 December 2019
- Publisher
- eScholarship, University of California